BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
Accessnewswireยท2025-09-15 07:05
Core Insights - BioNxt Solutions Inc. has successfully completed proof-of-concept trials for its Semaglutide oral dissolvable film program at its wholly owned subsidiary, Vektor Pharma TF GmbH [1] Group 1 - The trials involved the evaluation of multiple proprietary film platforms at Vektor Pharma [1]